Add Yahoo as a preferred source to see more of our stories on Google. The study was relatively small and involved 48 people who showed signs of moderate AUD who weren’t seeking treatment. Each female ...

A medication that’s made headlines for its weight loss effects might hold another life-changing secret. New research suggests that semaglutide, the active ingredient in popular medications Ozempic and ...

Originally designed for diabetes and obesity, GLP-1-based drugs may also blunt the brain's reward signals that drive alcohol, tobacco and drug cravings.

The active ingredient in Ozempic and Wegovy was linked to reduced cravings for drinking alcohol among people with alcohol use disorder, according to a small study published Wednesday in the journal ...

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...

REASONABLE RESTRICTIONS ON ADVERTISING PRACTICES. FIVE ON YOUR MENTAL HEALTH TONIGHT, A MAJOR DEVELOPMENT FOR AMERICANS STRUGGLING WITH ALCOHOL USE, RESEARCHERS SAY THE SAME DRUG THAT HELPS PEOPLE ...

Researchers think they know why GLP-1 drugs appear to reduce alcohol cravings GLP-1 drugs slow the speed at which alcohol enters the bloodstream This diminishes its effects on a person’s brain ...

(NEW YORK) — Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit — it could help people drink less alcohol. A study published in JAMA Psychiatry ...

As wellness conversations broaden beyond abstinence, new research explores cannabis through a harm-reduction lens and what it could mean for moderating alcohol consumption.

Since GLP-1s hit the mainstream roughly two years ago, people taking the weight-loss drugs noticed their cravings for food disappear. For some, that extended to alcohol, too. Now, the growing buzz ...